
GEOVAX LABS INC- WARRANTS
Acción · US3736781192 · GOVXW (XNAS)
0,03 USD
04.06.2025 16:27
Cotizaciones actuales de GEOVAX LABS INC- WARRANTS
Bolsa | Ticker | Moneda | Última operación | Precio | Variación diaria |
---|---|---|---|---|---|
![]() NASDAQ |
GOVXW
|
USD
|
04.06.2025 16:27
|
0,03 USD
| 0,03 USD
-3,70 %
|
Performance
Heute | Woche | Monat | 3 Monate | 6 Monate | 1 Jahr | 5 Jahre |
---|---|---|---|---|---|---|
0,00 % | -0,27 % | 83,66 % | -66,39 % | -73,80 % | -10,37 % | -96,05 % |
Firmenprofil zu GEOVAX LABS INC- WARRANTS Aktie
GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and solid tumor cancers using modified vaccinia ankara virus-like particle vaccine platform. It is developing various preventive vaccines against (COVID-19), human immunodeficiency virus (HIV); Zika virus; malaria; and hemorrhagic fever viruses, such as Ebola, Sudan, Marburg, and Lassa, as well as therapeutic vaccines for HIV, chronic Hepatitis B infections, and solid tumor cancers. The company is developing GEO-CM04S1, a vaccine candidate that is in Phase 2 clinical trial for the treatment of preventive COVID-19; Gedeptin, a novel patented product/technology for the treatment of solid tumors, and Phase 1/2 clinical trial for the treatment of advanced head and neck squamous cell carcinoma; and GEO-CM02, a pan-coronavirus vaccine. In addition, it is also developing GEO-ZM02, a vaccine candidate, which is in preclinical trial for the treatment of GEO-ZM02, a vaccine candidate, which is in preclinical trial for the treatment of Zika; GEO-MM02 treatment for malaria; GEO-EM01 for the treatment of fever viruses, such as Ebola, Sudan, and Marburg; GEO-LM01 for the treatment of Lassa fever. GeoVax Labs, Inc. has collaboration and partnership agreements with the National Institute of Allergy and Infectious Diseases of the National Institutes of Health; U.S. Department of Defense; Emory University; and the Burnet Institute. GeoVax Labs, Inc. was incorporated in 1988 and is headquartered in Smyrna, Georgia.
Unternehmensdaten
Name GEOVAX LABS INC- WARRANTS
Firma GeoVax Labs, Inc.
Symbol GOVXW
Website
https://www.geovax.com
Heimatbörse
NASDAQ

ISIN US3736781192
Wertpapierart Aktie
Sektor Healthcare
Branche Biotechnology
CEO Mr. David Alan Dodd
Marktkapitalisierung 12 Mio
Land Vereinigte Staaten von Amerika
Währung USD
Mitarbeiter 0,0 T
Adresse 1900 Lake Park Drive, 30080 Smyrna
Ticker Symbole
Name | Symbol |
---|---|
NASDAQ | GOVXW |
Weitere Aktien
Investoren die GEOVAX LABS INC- WARRANTS die halten, haben auch folgende Aktien im Depot:
Die Finanzplattform MoneyPeak trackt und analysiert Investitionen und Portfolios.
Vom Wertpapier-Depot bis zum Crypto-Kauf.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.